Search

Search Results
Results 7711 - 7720 of 7731 for parkinson
  • Syquet XR
    Drug - 23 Sep 2021
    Consumer Medicine Information (CMI) about Syquet XR intended for persons living in Australia.
  • Hygroton 25
    Drug - 20 Sep 2021
    Consumer Medicine Information (CMI) about Hygroton 25 (Chlortalidone) intended for persons living in Australia.
  • Urocarb Tablets
    Drug - 30 Jul 2021
    Consumer Medicine Information (CMI) about Urocarb Tablets intended for persons living in Australia.
  • Oxytrol
    Drug - 16 Jun 2021
    Consumer Medicine Information (CMI) about Oxytrol intended for persons living in Australia.
  • Kytril Injection
    Drug - 19 Oct 2017
    Consumer Medicine Information (CMI) about Kytril Injection (granisetron hydrochloride) intended for persons living in Australia.
  • Kytril Tablets
    Drug - 19 Oct 2017
    Consumer Medicine Information (CMI) about Kytril Tablets (granisetron hydrochloride) intended for persons living in Australia.
  • Clozaril
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Clozaril intended for persons living in Australia.
  • Alleo Labs Corp.
    Supplier - 15 Oct 2024
    We're developing new medicines for Alzheimer's and Parkinson's disease.
  • Vincere Biosciences Inc
    Supplier - 22 Sep 2021
    Vincere develops small molecule therapeutics to improve mitochondrial quality. Natural mechanisms of mitochondrial quality control decline with age, leading to the neurodegeneration seen in...
  • APDM Wearable Technologies
    Supplier - 14 Nov 2018
    APDM’s mission is to develop and commercialize best-in-class solutions for quantifying human movement with wearable technologies.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback